GOEDDEL DAVID V — SEC Form 4 filings
SEC reporting owner CIK 1182464. 6 Form 4 filings on record with FilingPulse; latest filed 2025-05-30.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-14 to 2025-05-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 37,936,506 shares, $34,999,998 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: purchase of 35,714,284 shares @ $0.70 ($24,999,999) in Tenaya Therapeutics, Inc., filed 2025-03-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | Director, 10% owner | 4 | 2 legs · 37,936,506 sh · $34,999,998 | — | 4 |
| NGM BIOPHARMACEUTICALS INC (NGM) | Director, 10% owner | 1 | — | — | 19 |
| RAPT Therapeutics, Inc. (RAPT) | 10% owner | 1 | — | — | 4 |
Form 4 filings — GOEDDEL DAVID V
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-05-30 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 107,400 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Purchase (P): 35,714,284 @ $0.70 · Purchase (P): 35,714,284 (derivative) · Purchase (P): 17,857,142 (derivative) | EDGAR |
| 2024-12-23 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim, Svennilson Peter, Column Group LLC | Other (J): 1,352,008 · Other (J): 1,599,417 · Other (J): 1,352,008 (derivative) · Other (J): 1,599,417 (derivative) | EDGAR |
| 2024-10-21 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) | Disposition to issuer (D): 134,180 · Disposition to issuer (D): 190,000 · Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · +13 more | EDGAR |
| 2024-02-14 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Purchase (P): 2,222,222 @ $4.50 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1182464 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →